Ramucirumab (Cyramza): A breakthrough treatment for gastric cancer

摘要

Gastric cancer is the fourth most common malignancy in men and the fifth most common malignancy in women worldwide. It is a common cancer in Japan, China, Southern and Eastern Europe, and South and Central America. In the United States, higher diagnosis rates are seen among Hispanic-Americans, African-Americans, Asians, and Pacific Islanders than in non-Hispanic whites. An estimated 22,220 new cases of gastric cancer and 10,990 deaths occurred in the United States in 2014,The median age at diagnosis is 69 years, and five-year survival following diagnosis is 28.3%.